Die polyzystische Lebererkrankung vom Typ 1 ist eine autosomal dominante Erkrankung die durch Mutationen im PRKCSH-Gen hervorgerufen wird.
![]() |
||||
![]() |
![]() ![]() |
|||
![]() |
![]() |
|||
![]() |
![]() |
![]() ![]() |
||
![]() |
![]() |
|||
![]() |
![]() |
![]() |
![]() |
![]() |
1. |
Reynolds DM et al. (2000) Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. ![]() |
2. |
Li A et al. (2003) Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. ![]() |
3. |
Drenth JP et al. (2003) Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. ![]() |
4. |
Sotaniemi EA et al. (1979) Impairment of drug metabolism in polycystic non-parasitic liver disease. ![]() |
5. |
Karhunen PJ et al. (1986) Adult polycystic liver and kidney diseases are separate entities. ![]() |
6. |
Berrebi G et al. (1982) Autosomal dominant polycystic liver disease: a second family. ![]() |
7. |
Luoma PV et al. (1980) Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver disease. ![]() |
8. |
OMIM.ORG article Omim 174050![]() |